Fluorescence Imaging on the da Vinci Surgical System for Intraoperative

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

A Prospective Investigation of the Use of the Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging of Renal Cortical Tumors. To determine the feasibility of the fluorescence imaging on the da Vinci Surgical System in robotic partial nephrectomy procedures and report perioperative outcomes.

See also
	Status	Clinical Trial	Phase
	Withdrawn	`NCT00858975` - Study of Cryotherapy for Renal Tumors	N/A
	Completed	`NCT01505569` - Auto Transplant for High Risk or Relapsed Solid or CNS Tumors	N/A

NCT number	NCT01104389
Study type	Interventional
Source	Intuitive Surgical
Contact
Status	Withdrawn
Phase	N/A
Start date	May 2010

Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms